Three cases of congenital cranial hemihypertrophy are described. CT or ultrasound scans showed unilateral cerebral enlargement with dilatation of the ipsilateral ventricle. Seizures occurred in two patients and the neurodevelopmental outlook appears poor.
A subclassification ofhemihypertrophy.
Complex Hemihypertrophy
Involves an entire half of the body, or at least an arm and a leg. Enlarged parts may be all on the same side (complex ipsilateral hemihypertrophy) or found on both sides (complex contralateral hemihypertrophy).
2 Simple Hemihypertrophy Involves a single limb.
3 Hemifacial Hypertrophy Involves one side of the face. Enlarged area bounded superiorly by the frontal bone (not including the eye), inferiorly by the inferior border of the mandible, medially by the midline of the face, and laterally by the ear, the pinna being included in the hypertrophic area.
Modified from Rowe.4 even part of one limb (for example, macrodactyly). We report three infants with craniofacial involvement in order to contribute to knowledge of the neurodevelopmental implications in this subgroup.
Case reports CASE 1 This was the first child of unrelated parents and there was no relevant family history. He was born at 36 weeks' gestation by emergency lower segment caesarian section (LSCS) for failure to progress in the second stage. Apgar scores were 2 and 5 at one and five minutes, respectively, and he was admitted to the Special Care Nursery for eight days with a diagnosis of perinatal asphyxia. His birth weight was normal, but the head circumference was >97th centile (table  2) and hemihypertrophy of the right side of the head At 9 months, the overgrowth has progressed and the head circumference remains above the 95th centile at 50 cm. Development is delayed, although she can reach for and hold objects, particularly with the left hand. CASE 3 This was the first of monochorionic twins delivered vaginally at 38 weeks' gestation. The parents are healthy and unrelated, and their previous child is well. There is no family history. His birth weight was well below the 3rd centile, but the head circumference was on the 40th centile' (table 2). His twin brother weighed just below the 3rd centile and his head circumference was on the 10th centile.
The pregnancy had been uneventful. A routine fetal ultrasound scan at 16 weeks' gestation had indicated a biparietal diameter on the 90th centile in twin 1, with marked enlargement of the left lateral ventricle. Twin 2 had normal ventricles and a biparietal diameter on the 25th centile.
At delivery, twin 1 had marked hypertrophy of the left side of the head (fig 3) , clinically more obvious in the lower face, and including the alveolar ridges. Cranial ultrasound showed marked dilatation of the left lateral ventricle, with slight dilatation of the right lateral and third ventricles. An organising haemorrhagic cast was present within the left lateral ventricle, suggestive of haemorrhage some weeks prenatally. Twin 2 appeared entirely normal clinically and had normal cranial ultrasound findings. Blood group analysis suggested monozygosity.
At 3 months, he had poor head control and the head circumference was rising inappropriately. CT scan showed enlargement of the left side of the brain, with marked dilatation of the ipsilateral ventricle, particularly affecting the temporal horn (fig 3) .
The rate of head growth slowed, but the head (TABLE 2) Age at onset Cranial hemihypertrophy was evident at birth in all three patients, and in one patient (case 3), the biparietal diameter was on the 90th centile with unilateral ventricular dilatation by fetal ultrasonography from 16 weeks' gestation. The abnormal pattern of overgrowth is therefore evident from an early stage of development.
Physical findings All tissue planes are affected by the hemihypertrophy, including cerebral substance, bone, soft tissue, and skin. There is a sharp demarkation in the midline, which is also seen in the tongue, dental ridges, and buccal mucosa. There is ventricular dilatation, particularly on the affected side, and evidence of cerebral hypertrophy.
Hyperpigmented and thickened skin changes were noted in case 2 at birth. A depigmented patch became evident in case 1 at the age of 6 months; no skin lesion has yet been found in case 3 at the age of 9 months. Ventricular dilatation and IVH Although two of our patients had evidence of perinatal intraventricular haemorrhage, it is unlikely that this was responsible for the ventricular dilatation. In case 1, the haemorrhage was in the contralateral ventricle and of a grade rarely causing ventriculomegaly. In case 3, the unilateral ventricular dilatation was already present at 16 weeks' gestation, five months before the observed haemorrhage.
Management of the ventricular dilatation
The rapidly enlarging heads and CT scan findings in all three children suggested unilateral hydrocephalus. However, in case 1, the insertion of a VP shunt did not influence the rate of head growth, and in case 3 the rate of head growth had slowed before the insertion of the VP shunt. It is premature to comment on the effect of the VP shunt on the subsequent pattern of head growth in case 3. It is possible that the early increase in head circumference represents hemimegalencephaly rather than raised intracranial pressure. Continued monitoring of the head circumferences in the three patients will clearly be important.
Neurodevelopment
All three patients showed delayed development. Cases 1 and 2 developed seizures at around 3 months of age, although in case 1 perinatal asphyxia may have been contributory.
HEMIHYPERTROPHY AND NEURODEVELOPMENT
There have been many reports of congenital hemihypertrophy since an early description by Meckel in 1822. 8 Where the hemihypertrophy includes the cranium, mental retardation and seizures appear more common. Rowe's classification does not include a category for patients such as ours with a cranial hemihypertrophy and, unfortunately, many of the earlier clinical descriptions are incomplete and list 'facial' asymmetry as a feature rather than commenting on the rest of the head. Recent reports in oral and facial surgery publications, such as that of Horswell et al,9 indicate that the hemifacial hypertrophy of Rowe4 does occur without cerebral involvement. In the light of the cases reported here, it seems likely that if hemihypertrophy extends to the cranial contents, producing a hemimegalencephaly,'0 then neurodevelopmental prognosis may be poor, and the frequency of retardation may be higher than the 15 to 28% reported for congenital hemihypertrophy generally. Conversely, if hemimegalencephaly is absent, the prognosis for intellect may well be excellent. It is therefore important to consider the possibility of cranial hemihypertrophy (or hemimegalencephaly) in any infant with a suggestive appearance and arrange appropriate investigation (cranial ultrasound or CT scan).
CRANIAL HEMIHYPERTROPHY AND SYNDROME DIAGNOSIS
The facial appearances of our patients might be mimicked by several syndromes, between which there is considerable overlap. The absence of cavernous haemangiomata and other vascular anomalies excludes Klippel-Trenaunay-Weber syndrome, and coupled with the lack of enchondromata makes Mafucci syndrome equally unlikely." In Bannayan syndrome,'2 the macrocephaly is usually symmetrical, and although hemihypertrophy can be a feature of Beckwith-Weidemann syndrome, there are no other physical characteristics to suggest this diagnosis.
Haberlund enceplnlocraniocutaneous lipomatosis (ECCL)'3 and Proteus syndrome'4 remain to be considered. Although one published case of the former bears a close facial resemblance to our cases,'5 the CT scan findings are quite distinct. In ECCL, on the same side as the dermatological and osseous abnormalities is found a porencephalic cyst with cerebral atrophy.'6 17 At necropsy, cerebral and meningeal lipomatosis with micropolygyria have also been described. 13 In our cases, however, the cerebral substance appears unilaterally hypertrophied, with ipsilateral dilatation of the lateral ventricle, and this corresponds more closely to the findings in those cases of Proteus syndrome where cranial hemihypertrojhy or intellectual deficit and seizures were reported. 120 In this context, it is worth noting that although intellect is said to be usually normal in Proteus syndrome, in 29 cases where adequate details were reported,'4 18-25 eight had psychomotor delay and, of these, six had clinical cranial hemihypertrophy or CT scan findings similar to those in our patients. Other features in favour of Proteus syndrome are the depigmented and raised pigmented skin lesions of cases 1 and 2, although against this diagnosis is the absence of exostoses and of the characteristic gyriform palm or sole lesions. Our patients are probably still young enough that such lesions might yet develop.
The markedly disparate CT scan findings in Proteus syndrome and ECCL noted here are of some interest in the light of the suggestion by Wiedemann and Burgio26 that ECCL may be "a more circumscript form of Proteus syndrome".
AETIOLOGY
Familial cases of hemihypertrophy are virtually unknown5 and it is generally accepted that the condition is sporadic (unless the hemihypertrophy is a manifestation of a hereditary disorder, such as neurofibromatosis). Case 3 supports this impression, being one member of a discordant monozygotic twin pair.
It is known that asymmetrical growth may be a feature of mosaicism and it has been argued that Proteus syndrome may result from somatic mutation27 giving rise to cell lines with abnormal growth patterns. Such a hypothesis would be attractive for hemihypertrophy generally, and to achieve regional hypertrophy affecting tissues of endodermal, mesodermal, and ectodermal origin, the mutation must presumably occur before the differentiation of these tissue layers. Case 3 showed abnormal growth from 16 weeks, but the mutation would have occurred long before this. In those cases of true complete hemihypertrophy, the change might have occurred at the two cell stage, and in cases of more localised hypertrophy, correspondingly later in development. The hypothesis of somatic mutation in a growth regulating gene may be supported by the association of Wilms' tumour with hemihypertrophy. 28 Whatever the aetiology, the three cases reported here serve to illustrate the poor neurodevelopmental prognosis associated with cranial hemihypertrophy, in distinction,from facial hemihypertrophy, as defined by Rowe.4 Early diagnosis may help in providing more accurate prognosis and hence better counselling for the parents. This is particularly so as there may be a great desire for cosmetic plastic surgery, a treatment which should be deferred until the probable neurological outcome is clear. From the relatively limited published reports available, it seems likely that similar cerebral abnormalities may be present in those with intellectual deficit in both 'congenital hemihypertrophy' and in Proteus syndrome. Further studies are needed to clarify this and the nature of the abnormal growth that is the hallmark of these patients.
